Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission
to discover, develop and deliver innovative medicines to patients with serious diseases.

Bristol-Myers Squibb International

Visit our global website for more information on Bristol-Myers Squibb worldwide.


June 2017 :
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for
Squamous Cell Cancer of the Head and Neck in Adults Progressing On or After Platinum-based Therapy

March 2017 :
Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer

January 2017 :
Opdivo is now reimbursed for four different types of cancer

Read more in our Press Releases in French & Dutch

Our Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Read more about our mission

Media and Press

For any information about us, our activities and disease areas, email our Public Affairs team via pressinfo.belgium@bms.com